Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1

被引:333
作者
Itahana, K
Zou, Y
Itahana, Y
Martinez, JL
Beausejour, C
Jacobs, JJL
van Lohuizen, M
Band, V
Campisi, J
Dimri, GP
机构
[1] Tufts Univ New England Med Ctr, Dept Radiat Oncol, Div Radiat & Canc Biol, Boston, MA 02111 USA
[2] Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA
[3] Calif Pacific Med Ctr, San Francisco, CA 94115 USA
[4] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands
关键词
D O I
10.1128/MCB.23.1.389-401.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The polycomb protein Bmi-1 represses the INK4a locus, which encodes the tumor suppressors p16 and p14(ARF). Here we report that Bmi-1 is downregulated when WI-38 human fibroblasts undergo replicative senescence, but not quiescence, and extends replicative life span when overexpressed. Life span extension by Bmi-1 required the pRb, but not p53, tumor suppressor protein. Deletion analysis showed that the RING finger and helix-turn-helix domains of Bmi-1 were required for life span extension and suppression of p16. Furthermore, a RING finger deletion mutant exhibited dominant negative activity, inducing p16 and premature senescence. Interestingly, presenescent cultures of some, but not all, human fibroblasts contained growth-arrested cells expressing high levels of p16 and apparently arrested by a p53- and telomere-independent mechanism. Bmi-1 selectively extended the life span of these cultures. Low O-2 concentrations had no effect on p16 levels or life span extension by Bmi-1 but reduced expression of the p53 target, p21. We propose that some human fibroblast strains are more sensitive to stress-induced senescence and have both p16-dependent and p53/telomere-dependent pathways of senescence. Our data suggest that Bmi-1 extends the replicative life span of human fibroblasts by suppressing the p16-dependent senescence pathway.
引用
收藏
页码:389 / 401
页数:13
相关论文
共 66 条
  • [21] HARA E, 1994, J BIOL CHEM, V269, P2139
  • [22] TELOMERES SHORTEN DURING AGING OF HUMAN FIBROBLASTS
    HARLEY, CB
    FUTCHER, AB
    GREIDER, CW
    [J]. NATURE, 1990, 345 (6274) : 458 - 460
  • [23] NOVEL ZINC FINGER GENE IMPLICATED AS MYC COLLABORATOR BY RETROVIRALLY ACCELERATED LYMPHOMAGENESIS IN E-MU-MYC TRANSGENIC MICE
    HAUPT, Y
    ALEXANDER, WS
    BARRI, G
    KLINKEN, SP
    ADAMS, JM
    [J]. CELL, 1991, 65 (05) : 753 - 763
  • [24] Regulation of cellular senescence by p53
    Itahana, K
    Dimri, G
    Campisi, J
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10): : 2784 - 2791
  • [25] A role for p53 in maintaining and establishing the quiescence growth arrest in human cells
    Itahana, K
    Dimri, GP
    Hara, E
    Itahana, Y
    Zou, Y
    Desprez, PY
    Campisi, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) : 18206 - 18214
  • [26] The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
    Jacobs, JJL
    Kieboom, K
    Marino, S
    DePinho, RA
    van Lohuizen, M
    [J]. NATURE, 1999, 397 (6715) : 164 - 168
  • [27] TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression
    Kaminker, PG
    Kim, SH
    Taylor, RD
    Zebarjadian, Y
    Funk, WD
    Morin, GB
    Yaswen, P
    Campisi, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) : 35891 - 35899
  • [28] Senescence induced by altered telomere state, not telomere loss
    Karlseder, J
    Smogorzewska, A
    de Lange, T
    [J]. SCIENCE, 2002, 295 (5564) : 2446 - 2449
  • [29] Features of replicative senescence induced by direct addition of antennapedia-p16INK4A fusion protein to human diploid fibroblasts
    Kato, D
    Miyazawa, K
    Ruas, M
    Starborg, M
    Wada, I
    Oka, T
    Sakai, T
    Peters, G
    Hara, E
    [J]. FEBS LETTERS, 1998, 427 (02) : 203 - 208
  • [30] Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung cancer cells in a p53-dependent manner
    Kawabe, S
    Roth, JA
    Wilson, DR
    Meyn, RE
    [J]. ONCOGENE, 2000, 19 (47) : 5359 - 5366